Jane O’Donnell , Georgia Doyle , Michaela Fletcher , Chantelle Maria Dick
{"title":"Nasal high flow therapy in the emergency department – A prospective study","authors":"Jane O’Donnell , Georgia Doyle , Michaela Fletcher , Chantelle Maria Dick","doi":"10.1016/j.ienj.2025.101660","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Globally, emergency department (ED) nurses routinely care for patients requiring respiratory support; this support may include nasal high flow (NHF) therapy.</div></div><div><h3>Objective</h3><div>The study objective was to profile and evaluate the outcomes of ED patients receiving NHF respiratory support compared to those receiving all other forms of respiratory support.</div></div><div><h3>Methods</h3><div>A prospective, observational, multicenter method was used to capture real-time, real-world epidemiological data at four New Zealand EDs for two 12-hour periods in April and May 2023. N = 898 patients presented to the participating EDs; the minority, n = 76 (8.46 %), received respiratory support, with a subset of these (<em>n</em> = 12, 15.7 %) receiving NHF.</div></div><div><h3>Results</h3><div>Most of those receiving NHF were male (<em>n</em> = 8, 66 %), of New Zealand European ethnicity (<em>n</em> = 4, 33 %), with a mean age of 69.91 years (SD 18.93). These participants had a mean triage score of 2.66 (SD 0.65) and a mean modified early warning score of 7.58 (SD 3.32). ‘Respiratory’ was the most common participant diagnostic category (<em>n</em> = 5, 41.5 %). The most common reason for NHF delivery was ‘oxygenation improvement’ (<em>n</em> = 4, 33.3 %).</div><div>Those receiving NHF appeared to require less escalation of respiratory support versus those receiving other forms of respiratory support (<em>n</em> = 1, 8.3 %, versus <em>n</em> = 21, 32.8 %). No significant difference in treatment effect was seen for escalation to NHF versus other forms of respiratory support (RR 0.31, 95 % CI 0.04 to 2.12, <em>P</em> = 0.23, NNT (benefit) 5.87, 95 % CI 2.43 to 14.07). The median overall length of stay for those admitted to the hospital was eight days (4–15). This was seen to be significantly higher for those receiving NHF in the ED (Mann-Whitney U, 183, <em>P</em> = 0.004).</div></div><div><h3>Conclusion</h3><div>Given the methods used, all findings must be viewed with caution. The study reports that a minority of ED patients requiring respiratory support receive NHF. However, these patients appear to have high acuities, a high need for hospitalization, and an increased length of stay (LOS). Collectively, these data suggest that these patients are high consumers of healthcare resources. These New Zealand study findings may have implications for research and care planning across health sectors, including the ED.</div></div><div><h3>Contribution to Emergency Nursing Practice</h3><div><strong>What is already known about this topic?</strong> Nasal high-flow therapy, which provides respiratory support, is provided in the emergency department to patients with many conditions.</div><div><strong>What does this paper add to the currently published literature?</strong> This description of the epidemiology of emergency department patients provided nasal high flow here may inform benchmarking for future ED clinical practice and research.</div><div><strong>What is the most important implication for clinical emergency nursing practice?</strong> The patients profiled in this study are vulnerable, have high acuity, and require targeted respiratory support to improve their outcomes.</div></div>","PeriodicalId":48914,"journal":{"name":"International Emergency Nursing","volume":"82 ","pages":"Article 101660"},"PeriodicalIF":1.8000,"publicationDate":"2025-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Emergency Nursing","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1755599X25000904","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"NURSING","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Globally, emergency department (ED) nurses routinely care for patients requiring respiratory support; this support may include nasal high flow (NHF) therapy.
Objective
The study objective was to profile and evaluate the outcomes of ED patients receiving NHF respiratory support compared to those receiving all other forms of respiratory support.
Methods
A prospective, observational, multicenter method was used to capture real-time, real-world epidemiological data at four New Zealand EDs for two 12-hour periods in April and May 2023. N = 898 patients presented to the participating EDs; the minority, n = 76 (8.46 %), received respiratory support, with a subset of these (n = 12, 15.7 %) receiving NHF.
Results
Most of those receiving NHF were male (n = 8, 66 %), of New Zealand European ethnicity (n = 4, 33 %), with a mean age of 69.91 years (SD 18.93). These participants had a mean triage score of 2.66 (SD 0.65) and a mean modified early warning score of 7.58 (SD 3.32). ‘Respiratory’ was the most common participant diagnostic category (n = 5, 41.5 %). The most common reason for NHF delivery was ‘oxygenation improvement’ (n = 4, 33.3 %).
Those receiving NHF appeared to require less escalation of respiratory support versus those receiving other forms of respiratory support (n = 1, 8.3 %, versus n = 21, 32.8 %). No significant difference in treatment effect was seen for escalation to NHF versus other forms of respiratory support (RR 0.31, 95 % CI 0.04 to 2.12, P = 0.23, NNT (benefit) 5.87, 95 % CI 2.43 to 14.07). The median overall length of stay for those admitted to the hospital was eight days (4–15). This was seen to be significantly higher for those receiving NHF in the ED (Mann-Whitney U, 183, P = 0.004).
Conclusion
Given the methods used, all findings must be viewed with caution. The study reports that a minority of ED patients requiring respiratory support receive NHF. However, these patients appear to have high acuities, a high need for hospitalization, and an increased length of stay (LOS). Collectively, these data suggest that these patients are high consumers of healthcare resources. These New Zealand study findings may have implications for research and care planning across health sectors, including the ED.
Contribution to Emergency Nursing Practice
What is already known about this topic? Nasal high-flow therapy, which provides respiratory support, is provided in the emergency department to patients with many conditions.
What does this paper add to the currently published literature? This description of the epidemiology of emergency department patients provided nasal high flow here may inform benchmarking for future ED clinical practice and research.
What is the most important implication for clinical emergency nursing practice? The patients profiled in this study are vulnerable, have high acuity, and require targeted respiratory support to improve their outcomes.
期刊介绍:
International Emergency Nursing is a peer-reviewed journal devoted to nurses and other professionals involved in emergency care. It aims to promote excellence through dissemination of high quality research findings, specialist knowledge and discussion of professional issues that reflect the diversity of this field. With an international readership and authorship, it provides a platform for practitioners worldwide to communicate and enhance the evidence-base of emergency care.
The journal publishes a broad range of papers, from personal reflection to primary research findings, created by first-time through to reputable authors from a number of disciplines. It brings together research from practice, education, theory, and operational management, relevant to all levels of staff working in emergency care settings worldwide.